SLE is an autoimmune disease in which immune complexes comprised of autoantibodies and self-antigens are deposited, particularly in the renal glomeruli, and mediate a systemic inflammatory response by activating complement or via Fcgamma receptor (FcgR)-mediated neutrophil and macrophage activation. This evidence concerns the gene FCGR2A and autoimmune disease.